Image: FafSilicon Valley at the Crossroads: How OpenAI’s IPO Push, the Apple Lawsuit, Chinese Open-Weight Models, and Deep-Tech Capital Are Redrawing the Global AI Order — Foreign Affairs Forum
• OpenAI researcher Miles Wang is departing the company to launch a new AI startup specifically focused on accelerating drug discovery. • Wang is currently in negotiations to raise approximately $200 million in funding, with a target valuation of $2 billion. • Venture capital firm Lightspeed is reportedly in discussions to lead the funding round for the new venture.
faf.ae


